The latest closing stock price for Gamida Cell as of June 12, 2020 is 4.75.. The all-time high Gamida Cell stock closing price was 15.41 on November 30, 2018.; The Gamida Cell 52-week high stock price is 7.70, which is 62.1% above the current share price. We have provided a few examples below that you can copy and paste to your site:Your image export is now complete. This might drive the stock higher in the near term. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.Gamida Cell Reports Second Quarter 2020 Financial Results and Provides Company UpdateGamida Cell Announces the Date of Its Second Quarter 2020 Financial Results and WebcastAlliance for Regenerative Medicine: The Alliance for Regenerative Medicine Releases List of Presenting Companies at the 2020The Alliance for Regenerative Medicine Releases List of Presenting Companies at the 2020 Cell & Gene Meeting on the MesaGamida Cell Announces Appointment of Michele Korfin as Chief Operating and Chief Commercial OfficerGamida Cell Announces Appointment of David Fox to Its Board of DirectorsGamida Cell to Present at the JMP Securities Virtual Hematology and Oncology ForumGamida Cell Announces Full Exercise of Underwriters’ Option to Purchase Additional SharesGamida Cell Reports First Quarter 2020 Financial Results and Provides Company UpdateGamida Cell Announces Pricing of $60 Million Public Offering of Ordinary SharesVaccine for All ‘Decent Amount’ of Weeks Away, Johns Hopkins' Sauer SaysGamida Cell Reports Second Quarter 2020 Financial Results and Provides Company UpdateGamida Cell Announces the Date of Its Second Quarter 2020 Financial Results and WebcastAlliance for Regenerative Medicine: The Alliance for Regenerative Medicine Releases List of Presenting Companies at the 2020The Alliance for Regenerative Medicine Releases List of Presenting Companies at the 2020 Cell & Gene Meeting on the MesaGamida Cell Announces Appointment of Michele Korfin as Chief Operating and Chief Commercial OfficerGamida Cell Announces Appointment of David Fox to Its Board of DirectorsGamida Cell to Present at the JMP Securities Virtual Hematology and Oncology ForumGamida Cell Announces Full Exercise of Underwriters’ Option to Purchase Additional SharesGamida Cell Reports First Quarter 2020 Financial Results and Provides Company UpdateGamida Cell Announces Pricing of $60 Million Public Offering of Ordinary SharesWhen autocomplete results are available use up and down arrows to review and enter to select. It focuses on developing cell therapies to cure cancer and rare and serious hematologic diseases. We have provided a few examples below that you can copy and paste to your site:Your data export is now complete. The latest closing stock price for Gamida Cell as of August 11, 2020 is Gamida Cell Ltd. is a biopharmaceutical company.
The company's product pipeline consists of NiCord and NAM-NK which are in clinical stage. Historical daily share price chart and data for Gamida Cell since 2020 adjusted for splits. Touch device users, explore by touch or with swipe gestures. Please check your download folder. It operates primarily in the United States, the European Union and internationally. Find the latest Gamida Cell Ltd. (GMDA) stock quote, history, news and other vital information to help you with your stock trading and investing.
Gamida Cell (GMDA) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. Shares of Gamida Cell (NASDAQ:GMDA) moved higher by 1.6% in pre-market trading after the company reported Q2 results.Quarterly Results Earnings per share … Backlinks from other websites are the lifeblood of our site and a primary source of new traffic.If you use our chart images on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. GMDA: Get the latest Gamida Cell stock price and detailed information including GMDA news, historical charts and realtime prices. Gamida Cell Ltd. Stock Price Forecast, GMDA stock price prediction. Please check your download folder. Historical daily share price chart and data for Gamida Cell since 2020 adjusted for splits. BOSTON--(BUSINESS WIRE)--Oct. 26, 2018-- Gamida Cell Ltd., a leading cellular and immune therapeutics company, today announced the pricing of its initial public offering of 6,250,000 ordinary shares at a public offering price of $8.00 per share for aggregate gross proceeds of $50.0 million.All of the shares in the offering are being offered by Gamida Cell.